Pharma Industry online Certification Process starts: Gujarat

These certificates, crucial for the pharma industry, have successfully completed trial runs in collaboration with the NIC

140
Certificate Report, Audit, Inspection, Documents , medicine FDA
Picture: Pixabay

Last Updated on September 3, 2023 by The Health Master

Pharma Industry

In a significant stride towards enhancing the Ease of Doing Business (EoDB) in the pharma industry, the Gujarat Food and Drugs Control Administration (FDCA) is gearing up to launch its Non Conviction Certificates (NCC) and Performance Certificates (PC) issuance process online starting in September 2023.

These certificates, crucial for the pharma industry, have successfully completed trial runs in collaboration with the National Informatics Centre (NIC), marking a progressive step towards digital governance.

Collaboration with NIC to Enhance EoDB

The recent trial runs carried out by the Gujarat FDCA, in partnership with the National Informatics Centre (NIC), have paved the way for granting non-conviction certificates (NCC) and Performance Certificates (PC) to the pharma industry through an online platform.

This move aligns with the administration’s commitment to making the business environment more conducive and efficient.

Ensuring Compliance in Pharma Industry

The non-conviction certificate (NCC) holds particular importance within the pharmaceutical realm. It is a prerequisite for manufacturers participating in government medicine supply tenders.

This document assures the procurement agency that the manufacturer has not been convicted for any violations of the Drugs and Cosmetics (D&C) Act, 1940, and Rules 1945 for sales units.

Notably, Micro, Small, and Medium Enterprises (MSMEs) often engage in the tender process to fulfill the supply requirements of state governments.

Digital Transformation for Regulatory Strength

Gujarat FDCA Commissioner, Dr. H. G. Koshia, emphasized that the shift towards online issuance of certificates is integral to strengthening the drug regulatory system in Gujarat.

This transition also complements the upcoming rollout of the Gujarat FDCA’s flagship m-governance program, which has successfully completed all three phases of the safety audit.

The m-governance initiative is poised to benefit around 55,600 stakeholders, including:

  • 3,800 allopathic drug manufacturers and
  • 50,000 drug retailers and wholesalers.

Seamless Access through M-Governance

The m-governance program is set to revolutionize the way stakeholders interact with regulatory processes.

A unified mobile application will consolidate all online platforms, providing stakeholders, such as manufacturers and retailers, with real-time access to application statuses.

This strategic move ensures accountability, transparency, inclusivity, uniformity, and timeliness, all while seamlessly integrating with existing systems and protocols.

Conclusion

Gujarat FDCA’s forthcoming online initiative for NCC and PC issuance, in collaboration with NIC, signifies a transformative step towards a more efficient and digitally enabled pharmaceutical regulatory landscape.

The embrace of modern technology, accountability, and transparency promises to bolster the Ease of Doing Business for stakeholders across the pharmaceutical sector.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news